Literature DB >> 8569090

Rat mesangial cells in vitro synthesize a spectrum of proteoglycan species including those of the basement membrane and interstitium.

G J Thomas1, L Shewring, K J McCarthy, J R Couchman, R M Mason, M Davies.   

Abstract

Accumulation of extracellular matrix within the mesangium is an important event in the development of glomerular disease. In this report we have used indirect immunofluorescence to positively identify a number of constituents of the mesangial matrix synthesized by rat mesangial cells (RMC) in vitro including laminin, fibronectin, type IV collagen and the basement membrane heparan sulphate proteoglycan (BM-HSPG) known as perlecan. In addition, using Mab 2B5 we demonstrate that RMC synthesize a specific basement membrane chondroitin sulfate (BM-CSPG), a matrix component that in normal animals is localized in the mesangium but is not found in the pericapillary glomerular basement membrane (GBM). Further characterization of the proteoglycans synthesized by RMC in vitro revealed: (i) a second large CSPG, identified as versican; (ii) two small dermatan sulphate proteoglycans identified as biglycan and decorin, which together account for the majority of the proteoglycans; (iii) a large HSPG-I, probably related to perlecan; and (iv) a small HSPG-II. The cell layer proteoglycans can be sub-divided into a class that are probably free in the membrane, and a class of anchored molecules of the extracellular matrix or stabilized by cytoskeletal elements.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8569090     DOI: 10.1038/ki.1995.412

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  7 in total

1.  Glucose stimulation of transforming growth factor-beta bioactivity in mesangial cells is mediated by thrombospondin-1.

Authors:  M H Poczatek; C Hugo; V Darley-Usmar; J E Murphy-Ullrich
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  The distribution and regulation of integrin-linked kinase in normal and diabetic kidneys.

Authors:  L Guo; P W Sanders; A Woods; C Wu
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

3.  Structural and functional changes in heparan sulfate proteoglycan expression associated with the myofibroblastic phenotype.

Authors:  Gareth Thomas; Aled Clayton; Janet Thomas; Malcolm Davies; Robert Steadman
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

Review 4.  The glomerular basement membrane as a model system to study the bioactivity of heparan sulfate glycosaminoglycans.

Authors:  Kevin J McCarthy; Deborah J Wassenhove-McCarthy
Journal:  Microsc Microanal       Date:  2012-02       Impact factor: 4.127

5.  Hyaluronan induces the selective accumulation of matrix- and cell-associated proteoglycans by mesangial cells.

Authors:  Sabine Kastner; Gareth J Thomas; Robert H Jenkins; Malcolm Davies; Robert Steadman
Journal:  Am J Pathol       Date:  2007-11-01       Impact factor: 4.307

6.  Advances in targeting drug delivery to glomerular mesangial cells by long circulating cationic liposomes for the treatment of glomerulonephritis.

Authors:  Katsumi Morimoto; Masayo Kondo; Kazuo Kawahara; Hideto Ushijima; Yasuhiko Tomino; Masaharu Miyajima; Junji Kimura
Journal:  Pharm Res       Date:  2007-03-20       Impact factor: 4.580

7.  Differential expression of parietal epithelial cell and podocyte extracellular matrix proteins in focal segmental glomerulosclerosis and diabetic nephropathy.

Authors:  Gek Cher Chan; Diana G Eng; Jeffrey H Miner; Charles E Alpers; Kelly Hudkins; Anthony Chang; Jeffrey W Pippin; Stuart J Shankland
Journal:  Am J Physiol Renal Physiol       Date:  2019-10-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.